Characteristics of propensity score matched groups. by Clemens Plattner (21567706)

Subjects:

Comparative costs of HCVST and PL-HCVT models in sensitivity analysis (in US$). by Bao Vu Ngoc (14551955)

Subjects:

HCV positivity rate by key population group opting for HCVST and standard HCVT. by Bao Vu Ngoc (14551955)

Subjects:

Characteristics of propensity score matched groups. by Clemens Plattner (21567706)

Subjects:

Demographic characteristics of study participants. by Bao Vu Ngoc (14551955)

Subjects:

Proportion of first-time HCV testers by testing model. by Bao Vu Ngoc (14551955)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

New visits, types of health events, procedure, and outcome of health events during all of 2020, and during the BR-period, Ramadan period, and AR-period. by Taizo Sakata (21567847)

Subjects:

Age and sex of patients who visited the PHC during all of 2020, and during the BR-period, Ramadan period, and AR-period. by Taizo Sakata (21567847)

Subjects:

Seven-day moving average number of PHC visits and health events during 2020. by Taizo Sakata (21567847)

Subjects:

Age and sex of the refugee community in Camp 14 and in host communities. by Taizo Sakata (21567847)

Subjects:

Sodium levels (mg/100 g) in matched restaurant menu items in 2016 and 2020 by UK NSRI food categories with ≥ 10 items. by Caroline G. Middleton (22041479)

(a) Change rates were calculated for each transect along the coastlines from 1985 to 2023; (b) Coastline change rates of the Caspian Sea based on the EPR and LRR. by Zihao Duan (17403792)

Sodium levels in Canadian restaurant menu items compared to UK National Salt Reduction Initiative (NSRI) targets by UK NSRI food category. by Caroline G. Middleton (22041479)

Hypothesis 3: The mean difference between “Class 1” (a school attack happens within <i>k</i> kms. of a given school) and “Class 0” (no school attack happens within <i>k</i> kms. of... by Lirika Sola (21560710)

A comparison of <i>E. coli</i> contamination at Traditional Lanna restaurants before and after the model’s implementation. by Vivat Keawdounglek (9710710)